Related Experiment Videos
Maximizing the hemodynamic benefit of enhanced external counterpulsation
K Suresh1, S Simandl, W E Lawson
1Division of Cardiology, SUNY, Health Sciences Center, Stony Brook 11794, USA.
Clinical Cardiology
|October 2, 1998
Summary
The optimal ratio of diastolic augmentation to systolic unloading during enhanced external counterpulsation (EECP) is between 1.5 and 2.0. This range maximizes hemodynamic effects for patients with coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Enhanced external counterpulsation (EECP) is an established treatment for angina and exertional ischemia in coronary artery disease patients.
- The mechanism by which EECP enhances coronary collaterals is not fully understood.
- The effectiveness of EECP may depend on the balance between diastolic augmentation (DA) and systolic unloading (SU).
Purpose of the Study:
- To investigate the relationship between the EECP effectiveness ratio (DA/SU) and hemodynamic changes.
- To determine the optimal DA/SU ratio for maximizing EECP's therapeutic effects.
- To assess changes in descending aortic flow using Doppler echocardiography during EECP.
Main Methods:
- Fifteen patients with coronary artery disease underwent EECP with varying cuff pressures (0-275 mmHg) to achieve different DA/SU ratios.
- Finger plethysmography was used to assess the DA/SU ratio.
- Doppler echocardiography measured antegrade systolic and retrograde diastolic flow in the descending aorta.
Main Results:
- Increasing the DA/SU ratio initially led to a linear increase in both systolic and diastolic aortic flow.
- Systolic flow volume reached its maximum at a DA/SU ratio of 1.5.
- Diastolic flow volume was maximized at a DA/SU ratio of 2.0.
Conclusions:
- An EECP effectiveness ratio (DA/SU) between 1.5 and 2.0 is optimal for maximizing hemodynamic benefits.
- These findings provide a basis for optimizing EECP therapy in patients with coronary artery disease.
- Further research can explore the long-term clinical impact of this optimized EECP ratio.